W. Rathmell
Last active: 11/27/2019

W. Rathmell M.D., Ph.D. - Publications

  1. Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects. Simon JM, Hacker KE, Singh D, Brannon AR, Parker JS, Weiser M, Ho TH, Kuan PF, Jonasch E, Furey TS, Prins JF, Lieb JD, Rathmell WK, Davis IJ (2014) Genome Res 24(2): 241-50
    › Primary publication · 24158655 (PubMed) · PMC3912414 (PubMed Central)
  2. The somatic genomic landscape of chromophobe renal cell carcinoma. Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H, Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, Biehl M, Seth S, Kaipparettu BA, Bristow CA, Donehower LA, Wallen EM, Smith AB, Tickoo SK, Tamboli P, Reuter V, Schmidt LS, Hsieh JJ, Choueiri TK, Hakimi AA, The Cancer Genome Atlas Research Network, Chin L, Meyerson M, Kucherlapati R, Park WY, Robertson AG, Laird PW, Henske EP, Kwiatkowski DJ, Park PJ, Morgan M, Shuch B, Muzny D, Wheeler DA, Linehan WM, Gibbs RA, Rathmell WK, Creighton CJ (2014) Cancer Cell 26(3): 319-330
    › Primary publication · 25155756 (PubMed) · PMC4160352 (PubMed Central)
  3. Seeing the forest for the trees: kidney oncogenomes in relation to therapeutic outcomes. Chism DD, Rathmell WK (2014) Clin Cancer Res 20(7): 1721-3
    › Primary publication · 24634386 (PubMed) · PMC4077661 (PubMed Central)
  4. Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database--UNC GOLD. Gallagher SA, Smith AB, Matthews JE, Potter CW, Woods ME, Raynor M, Wallen EM, Rathmell WK, Whang YE, Kim WY, Godley PA, Chen RC, Wang A, You C, Barocas DA, Pruthi RS, Nielsen ME, Milowsky MI (2014) Urol Oncol 32(1): 32.e1-9
    › Primary publication · 23434424 (PubMed) · PMC4058502 (PubMed Central)
  5. Reply to Alexander S. Parker, Brad C. Leibovich, Jeanette E. Eckel-Passow, John C. Cheville's letter to the editor re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. ClearCode34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84. Rathmell WK, Brooks SA, Parker JS, Nielsen ME (2014) Eur Urol 66(5): e92
    › Primary publication · 25037640 (PubMed) · PMC4294998 (PubMed Central)
  6. Renal cell carcinoma. Jonasch E, Gao J, Rathmell WK (2014) BMJ : g4797
    › Primary publication · 25385470 (PubMed) · PMC4707715 (PubMed Central)
  7. PET/CT with (124)I-cG250: great potential and some open questions. Khandani AH, Rathmell WK, Wallen EM, Ivanovic M (2014) AJR Am J Roentgenol 203(2): 261-2
    › Primary publication · 25055257 (PubMed)
  8. Integrated genomic characterization of papillary thyroid carcinoma. Cancer Genome Atlas Research Network (2014) Cell 159(3): 676-90
    › Primary publication · 25417114 (PubMed) · PMC4243044 (PubMed Central)
  9. HIF1α and HIF2α exert distinct nutrient preferences in renal cells. Arreola A, Cowey CL, Coloff JL, Rathmell JC, Rathmell WK (2014) PLoS One 9(5): e98705
    › Primary publication · 24879016 (PubMed) · PMC4039535 (PubMed Central)
  10. Genomic investigation of etiologic heterogeneity: methodologic challenges. Begg CB, Seshan VE, Zabor EC, Furberg H, Arora A, Shen R, Maranchie JK, Nielsen ME, Rathmell WK, Signoretti S, Tamboli P, Karam JA, Choueiri TK, Hakimi AA, Hsieh JJ (2014) BMC Med Res Methodol : 138
    › Primary publication · 25532962 (PubMed) · PMC4292824 (PubMed Central)